Icon

GANZYK-RTU (nda209347)- (500MG/250ML (2MG/ML))

GANCICLOVIR EXELA PHARMA
500MG/250ML (2MG/ML)
No Yes
2034-Sep-02 Expired
None None
None No
GANCICLOVIR INJECTION is a nucleoside analogue CMV DNA polymerase inhibitor indicated for the: • Treatment of CMV retinitis in immunocompromised adult patients, including patients with acquired immunodeficiency syndrome (AIDS). • Prevention of CMV disease in adult transplant recipients at risk for CMV disease.
0 0 0
Total Other Developers None
Drugs with Suitability No
500MG/250ML (2MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

GenUs Advanced Search




Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.